Preparation of 3,4-fused-spiro[furan-5(5H),4′-piperidin]-2-one
摘要:
A general method for the preparation of various 3,4-fused-spiro[furan-5(5H),4'-piperidini-2-one with high yield is reported. The formation of spiro[furarione-piperidine] structure was achieved by a Suzuki coupling, followed by an iodolactonization reaction. (C) 2009 Elsevier Ltd. All rights reserved.
[EN] ACYLATED SPIROPIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS [FR] DERIVES SPIROPIPERIDINES ACYLES CONVENANT COMME MODULATEURS DES RECEPTEURS DE LA MELANOCORTINE-4
[EN] ACYLATED SPIROPIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS<br/>[FR] DERIVES SPIROPIPERIDINES ACYLES CONVENANT COMME MODULATEURS DES RECEPTEURS DE LA MELANOCORTINE-4
申请人:MERCK & CO INC
公开号:WO2007041052A3
公开(公告)日:2007-05-31
ACYLATED SPIROPIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS
申请人:Merck Sharp & Dohme Corp.
公开号:EP1940842B1
公开(公告)日:2012-05-30
Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators
申请人:Jian Tianying
公开号:US20090170863A1
公开(公告)日:2009-07-02
Certain novel N-acylated spiropiperidine derivatives are ligands of the human melanocortin receptor(s) and, in particular, are selective ligands of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of MC-4R, such as obesity, diabetes, nicotine addiction, alcoholism, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
US8293900B2
申请人:——
公开号:US8293900B2
公开(公告)日:2012-10-23
Preparation of 3,4-fused-spiro[furan-5(5H),4′-piperidin]-2-one
作者:Jian Liu、Tianying Jian、Liangqin Guo、Tzvetomira Atanasova、Ravi P. Nargund
DOI:10.1016/j.tetlet.2009.07.035
日期:2009.9
A general method for the preparation of various 3,4-fused-spiro[furan-5(5H),4'-piperidini-2-one with high yield is reported. The formation of spiro[furarione-piperidine] structure was achieved by a Suzuki coupling, followed by an iodolactonization reaction. (C) 2009 Elsevier Ltd. All rights reserved.